Cluster Health & Mission Cancer Brokerage Event

28 Sept 2026 | Brussels, Belgium

Register
Register
Register

ADLIN Science

Start-up

www.adlin-science.com/enParis, France
4 profile visits

About

ADLIN Science is a French deeptech company specializing in health data management, secure multi-site data sharing, and interactive multi-omics analysis. Our mission is to accelerate biomedical research and precision medicine by making sensitive health data usable, safely and at scale, without compromising data sovereignty.

Our platform covers the full data lifecycle: structuring and quality control of heterogeneous clinical and omics data; secure sharing and visualization through a "data visiting" architecture, which allows multi-site collaborative analysis while data remains hosted on its source infrastructure; and interactive exploration of multiomics datasets — transcriptomics, genomics, and proteomics — through intuitive, no-code interfaces for clinicians and researchers, complemented by advanced tools for bioinformaticians.

ADLIN's track record includes S4K (Share4Kids), a multi-site paediatric oncology data-sharing registry, and Alliance Santé IA, a hospital-industry collaboration on data sovereignty and AI built with Montpellier University Hospital.

We work with hospitals, research institutes, CROs, and pharmaceutical/biotech companies across Europe, and are actively expanding our partnership network for European research and innovation programmes, including Horizon Europe consortia. We are seeking partners and consortium opportunities where secure, sovereignty-compliant multi-omics data infrastructure, cross-institutional data governance, and collaborative data exploration are critical — particularly in oncology, rare diseases, and translational research.

Representatives

Chief Business Officer

ADLIN Science

Marketplace (1)

  • Project cooperation

    Data infrastructure, governance and multi-omics data integration/visualisation

    ADLIN is looking to join consortia as the SME partner for secure data infrastructure, governance and multi-omics data integration/visualisation, supporting functional genomics research on cancer heterogeneity and novel therapeutic targets.

    • Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    Author

    Chief Business Officer at ADLIN Science

    Paris, France